Yeast model reveals Alzheimer's drug candidate and its mechanism of action
Using a yeast model of Alzheimer's disease (AD), Whitehead Institute researchers have identified a drug that reduces levels of the toxic protein fragment amyloid-β (Aβ) and prevents at least some of the cellular damage ...
Mar 4, 2014
0
0